Suspension of trading
Intellipharmaceutics International Inc. Stock Deutsche Boerse AG
Stocks
I4AA
CA4581733090
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0445 EUR | -13.59% |
|
-.--% | - |
| Market Cap | 1.41M 1.22M 1.14M 1.04M 1.96M 134M 1.99M 13.38M 5.24M 67.14M 5.28M 5.17M 224M | P/E 2021 |
-0.69x | P/E 2022 | -0.82x |
|---|---|---|---|---|---|
| Enterprise Value | 3.65M 3.16M 2.96M 2.7M 5.08M 348M 5.17M 34.71M 13.6M 174M 13.7M 13.4M 581M | EV / Sales 2021 |
-
| EV / Sales 2022 | 70.4x |
| Free-Float |
98.24% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -13.59% |
| 3 years | 0.03 |  | 0.08 |
| 5 years | 0.01 | | 0.18 |
| 10 years | 0.01 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amina Odidi
DFI | Director of Finance/CFO | - | - |
| Comptroller/Controller/Auditor | - | 01/04/2007 | |
| Corporate Officer/Principal | - | 01/02/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Amina Odidi
BRD | Director/Board Member | - | 01/09/2004 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 14/2/24 | Option | Director | 100,000 | 0.3022% | ||
| 13/2/24 | Option | Director | 120,000 | 0.3626% | ||
| 13/2/24 | Option | Executive/Senior Manager | 200,000 | 0.6044% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -13.59% | -.--% | - | - | 33 | |
| -1.37% | +8.90% | +91.28% | +130.00% | 1,083B | |
| -0.77% | +1.91% | +49.46% | +49.44% | 626B | |
| +0.85% | +2.58% | +25.90% | +64.34% | 442B | |
| -1.13% | +3.13% | +49.78% | +39.13% | 363B | |
| -0.74% | +1.01% | +31.08% | +38.64% | 295B | |
| -1.22% | +0.89% | +7.32% | +7.38% | 248B | |
| -0.70% | +6.23% | +45.32% | +57.82% | 224B | |
| +0.34% | -0.13% | -4.77% | -50.50% | 210B | |
| +2.04% | +0.38% | +12.70% | +69.71% | 168B | |
| Average | -1.63% | +1,662.85% | +34.23% | +45.11% | 406.57B | |
| Weighted average by Cap. | -0.62% | +1,332.62% | +49.63% | +66.05% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | 65.73K 56.96K 53.32K 48.65K 91.56K 6.27M 93.1K 625K 245K 3.14M 247K 241K 10.47M |
| Net income | -5.15M -4.46M -4.17M -3.81M -7.17M -491M -7.29M -48.94M -19.18M -246M -19.32M -18.9M -819M | -2.89M -2.51M -2.35M -2.14M -4.03M -276M -4.1M -27.51M -10.78M -138M -10.86M -10.62M -461M |
| Net Debt | 1.15M 993K 929K 848K 1.6M 109M 1.62M 10.9M 4.27M 54.68M 4.3M 4.21M 182M | 2.24M 1.94M 1.82M 1.66M 3.12M 214M 3.18M 21.33M 8.36M 107M 8.42M 8.24M 357M |
Employees
11
Sector
Pharmaceuticals
- Stock Market
- Stocks
- IPCIQ Stock
- I4AA Stock
Select your edition
All financial news and data tailored to specific country editions
